Acute Respiratory Failure in a Patient With Idiopathic Pulmonary Fibrosis Following Nebulized and Intravenous Stem Cell Therapy

Kelly L. Cervellione, Janaya Raynor, Parool Desai, Craig A. Thurm


Idiopathic pulmonary fibrosis (IPF) is an uncommon disease with a poor prognosis. Recently, two medications were approved to slow progression of disease. However, due to the limited treatment options available, patients and their families often look to experimental and off-label treatments for support. One such option is stem cell therapy, which can be delivered in a variety of ways. Stem cells are being utilized both in and out of the context of closely monitored clinical trials. However, there is little evidence regarding the safety and efficacy of stem cell therapy for patients with IPF. Here we describe a case of a patient who received intravenous and nebulized stem cell therapy, which was followed by an acute exacerbation of his IPF. The exacerbation was successfully treated with corticosteroids and supportive care.

J Med Cases. 2017;8(10):301-304


Idiopathic pulmonary fibrosis; Stem cell therapy; Exacerbation

Full Text: HTML PDF
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe



Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board



Company Profile

Editorial Office

Misconduct and Retraction


Company Registration

Contact Us

Abstracting and Indexing



Instructions to Authors


Declaration of Helsinki

Contact Publisher

Submission Checklist


Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy


Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians


Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal


Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website:   editorial contact:
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.